Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dec 5, 2023 | ,

WASHINGTON, D.C. – Yesterday, U.S. Senator Rand Paul (R-KY) sent a letter to Dr. Robert Califf, Commissioner of Food and Drugs at the U.S. Food and Drug Administration (FDA) about the FDA’s recent proposed rule on Laboratory Developed Tests (LDTs). The proposed rule would inappropriately impose the FDA’s medical device regulatory framework on health care providers developing and performing LDTs as part of their professional practice. It would also cause unnecessary disruptions to patient care.

read more
Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dr. Rand Paul Introduces Legislation to Restore and Protect Americans’ Fourth Amendment Rights

Nov 30, 2023 | ,

WASHINGTON, D.C. – Today, U.S. Senator Rand Paul (R-KY) introduced the Fourth Amendment Restoration and Protection Act. A bill to restore and protect the Fourth Amendment rights of all Americans while still protecting national security. The bill would ensure Americans cannot be subjected to government surveillance upon the order of the secretive Foreign Intelligence Surveillance Court (FISC) or Executive Order 12333. While national security requires the ability to gather intelligence on foreign threats, using those authorities to conduct warrantless spying on Americans is an impermissible violation of the rights guaranteed to us by the Fourth Amendment.

read more
Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dr. Rand Paul Joins Effort to Demand Answers Over Biden Administration’s Unprecedented Pause of Firearms Export Licenses

Nov 21, 2023 | , ,

WASHINGTON, D.C. — Recently, U.S. Senator Rand Paul (R-KY) joined Senator Ted Budd (R-NC) and 44 other U.S. Senators in a letter to Secretary of Commerce Gina Raimondo raising questions over the decision announced last month by the Bureau of Industry and Security to pause for 90 days the issuance of export licenses for firearms, ammunition, and certain accessories to most overseas markets. This unprecedented move is the latest chapter in the Biden administration’s hostility towards America’s firearms industry.

read more
Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dr. Rand Paul Urges FDA to Update Animal Testing Guidance in Accordance with the FDA Modernization Act 2.0

Nov 20, 2023 | , ,

WASHINGTON, D.C. – Recently, U.S. Senator Rand Paul (R-KY), led a bipartisan group of nine senators in sending a letter to the U.S. Food and Drug Administration (FDA) to ensure the FDA is updating its animal testing regulations following the enactment of the FDA Modernization Act 2.0 last year. The legislation ended an outdated FDA mandate that required investigational new drugs to be tested on animals in pre-clinical trials. The legislation did not ban animal testing, but it allowed drug sponsors to use modern alternative methods to demonstrate a drug’s safety and effectiveness where they were suitable.

read more
Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dr. Rand Paul Joins Bipartisan Letter Urging the U.S. to End Prosecution of Julian Assange

Nov 14, 2023 | ,

WASHINGTON, D.C. – Recently, U.S. Senator Rand Paul (R-KY) and 15 other bipartisan Members of Congress sent a letter encouraging President Biden to end the extradition request currently pending against Australian publisher Julian Assange and halt all prosecutorial proceedings against him in an effort to preserve free speech and freedom of the press.

read more
Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dr. Rand Paul Forces Senate Vote on “Audit the Fed”

Nov 1, 2023 | ,

WASHINGTON, D.C. – Today, the U.S. Senate voted on U.S. Senator Rand Paul’s (R-KY) “Audit the Fed” legislation, which was introduced as an amendment to the pending spending bill in the Senate (Paul 1217). This legislation, also known as the Federal Reserve Transparency Act, would have prevented the Federal Reserve from concealing vital information on its operations from Congress.

read more
Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Senate to Vote on Dr. Rand Paul’s “Audit the Fed”

Nov 1, 2023 | , ,

WASHINGTON, D.C. – Today, the Senate will vote on U.S. Senator Rand Paul’s (R-KY) “Audit the Fed” legislation, which has been introduced as an amendment to the pending spending bill in the Senate (Paul 1217). This legislation, also known as the Federal Reserve Transparency Act, would prevent the Federal Reserve from concealing vital information on its operations from Congress.

read more